Navigation Links
Coronary angiography may improve outcomes for cardiac arrest patients
Date:3/31/2009

PITTSBURGH, March 31 People who suffer cardiac arrests and then receive coronary angiography are twice as likely to survive without significant brain damage compared with those who don't have the procedure, according to a study by University of Pittsburgh School of Medicine researchers. The study, published in the May/June issue of the Journal of Intensive Care Medicine and now available online, showed that patient outcomes improved with coronary angiography, an imaging procedure that shows how blood flows through the heart, regardless of certain clinical and demographic factors that influenced who received the procedure.

"Given the low odds of survival about 6 percent for patients who suffer out-of-hospital cardiac arrests, it's important to understand which treatments might make a difference in these dismal outcomes," noted Jon C. Rittenberger, M.D., corresponding author of the study and an assistant professor in the Department of Emergency Medicine at the University of Pittsburgh. The importance of prompt coronary angiography is well-established for cardiac arrest patients presenting with certain types of heart problems, Dr. Rittenberger noted. "But our study, which shows that angiography is independently associated with good neurologic outcomes, suggests that clinicians should consider the procedure for all post-cardiac arrest patients," he added.

Coronary angiography uses a contrast dye and X-rays to see the blood vessels and chambers of the heart. The procedure is usually done in conjunction with catheterization, which involves threading a thin hollow tube through an artery and into the heart. Dye is injected into the catheter and highlights any blockages in blood flow, which are then visible by X-ray.

The researchers retrospectively analyzed the charts of 241 adult cardiac arrest patients who were treated at UPMC Presbyterian Hospital, part of the University of Pittsburgh Medical Center, between January 1, 2005, an
'/>"/>

Contact: Wendy Zellner
ZellnerWL@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Number of Revascularization Procedures, Related In-Hospital Mortality and Some Complications Decline, While Rates of Infection and Acute Respiratory Distress Syndrome (ARDS) Following Coronary Artery Bypass Graft (CABG) Surgery Increase
2. Despite Patent Expiries of Leading Therapies, New Product Launches Will Drive a $4.6 Billion Increase in the Coronary Heart Disease Market
3. Stent 4 Life: A campaign is launched to increase the use of primary PCI in acute coronary patients
4. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
5. Society for Womens Health Research and MITA Promote Greater Awareness of Medical Imaging to Diagnose Womens Coronary Artery Disease
6. Traditional risk assessment tools do not accurately predict coronary heart disease
7. New Research Estimates 1500 Lives Could Be Saved Annually if the Lowest Performing Hospitals for Coronary Artery Bypass Graft Surgery Performed as Well as Top-ranking Hospitals
8. Coronary CTA: Non-invasive, low cost alternative for intermediate risk patients
9. Large study illustrates cardiac CT can effectively assess coronary artery disease
10. Mentice VIST(TM) New and Enhanced Carotid and Coronary Training Modules Take Medical Simulation Training to the Next Level
11. Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Stress May Raise Diabetes Risk for Obese Black Women 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 3Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 4Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 5Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 2Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 3Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 4Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 5Health News:Medifast, Inc. Announces Appointment of Two Additional Independent Board Members 2Health News:Medifast, Inc. Announces Appointment of Two Additional Independent Board Members 3Health News:Medifast, Inc. Announces Appointment of Two Additional Independent Board Members 4Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 2Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 3Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 4
Breaking Medicine Technology:Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 1L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 2L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 3Par Pharmaceutical to Host Analyst Day on December 3rd 6307 1NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 1NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 2NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 3NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 4NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 5